Two portfolio companies of the Africa Healthcare Fund (AHF1) and the Africa Innovation & Healthcare Fund (AHF2), managed by AAIC Investment Pte. Ltd. (Headquarters: Singapore; CEO: Susumu Tsubaki; hereinafter “AAIC”) , announced the signing of two MoUs in the healthcare-related field at the 9th Tokyo International Conference on African Development (hereinafter “TICAD 9”), held in Yokohama from August 20 to 22, 2025.
Additionally, at TICAD9, nine African startups that are investment targets of the fund and have shown remarkable growth were invited to discuss strengthening ties with Japanese companies and realizing a future healthcare ecosystem in Africa.
■Investment companies managed by our investment fund Signed MoU ( 2 )
① Recomed (operates the largest online hospital reservation system in South Africa) – Eisai Co., Ltd.: Collaboration between pharmaceutical company and IT company to improve access to healthcare
② Drugstoc (DX wholesaler selling pharmaceuticals to medical institutions and pharmacies in Nigeria) – Alfresa Holdings Corporation
Over 300 MoUs were signed at TICAD 9, with 64 of them introduced at the TICAD ceremony on Thursday, the 21st. Of the five healthcare-related MoUs, two were collaborations between companies in which our fund invests and Japanese companies.
■Other activities of AAIC Investment and its investee African companies at TICAD9
TICAD9 , various events were planned and presentations were held at various locations, so we would like to introduce them to you.
AAIC Director/CEO Susumu Tsubaki, AAIC Investment Director Shigeru Handa, and AAIC Nigeria Representative Nobuhiko Ichimiya will serve as Co-founder & Co-CEO of Gozem * . Raphael Dana , Drugstoc Together with Co -founder & CEO Chibuzo Opara , we discussed how the power of African startups to unite the dispersed market can be used to help Japanese companies enter the African market.
* Gozem : Developing a super app for ride-sharing, fintech, e-commerce, etc. in French-speaking West Africa
Scene from the venue
From left: AAIC Nigeria Representative Nobuhiko Ichimiya, AAIC Investment Director Shigeru Handa, Gozem Co-founder & Co-CEO Raphael Dana , AAIC Director/CEO Susumu Tsubaki, Drugstoc Co -founder & CEO Chibuzo Opara
Revital Healthcare ** aims to expand and deepen its business by building a network between Japan and Africa. Sales and Marketing Director Roneek Vora, along with AAIC Investment Director Handa, announced the partnership with Mitsui O.S.K. Lines, Ltd. and Ohara Pharmaceutical Co., Ltd.
**Revital Healthcare: Manufactures over 40 medical products in Kenya, including non-reusable syringes with WHO PQS certification, as well as malaria test kits, and exports them to sub-Saharan countries.
Left: Sales and Marketing Director Roneek Vora, AAIC Investment Director Shigeru Handa
More than 50 people from Japanese companies participated in the event. The panel discussion featured Mr. Mikio Oyama, Representative Director of Mitsui O.S.K. Lines East Africa, and seven invited African companies ( Rology , DeepEcho , Recomed , Drugstoc , Africa Healthcare Network, Revital Healthcare, and Gozem ), promoting business matching.
Scene from the venue
Rology *** Chief business officer/Co-Founder Moaaz Hossam won the Sysmex Award for Excellence.
*** Rology : Originating in Egypt. Provides a remote radiology diagnostic platform that connects hospitals with radiologists, who are in short supply. Expands across the Middle East and Africa, primarily in Egypt, Kenya, and Saudi Arabia.
Right: Moaaz Hossam, Chief Business Officer/Co-Founder of Rology
Through the implementation of this MoU , AAIC will contribute to efforts to promote innovation in healthcare , a growing and challenging area in Africa , together with local and Japanese companies.